Abstract
Sorting nexin 27 (SNX27), a brain-enriched PDZ domain protein, regulates endocytic sorting and trafficking. Here we show that Snx27−/− mice have severe neuronal deficits in the hippocampus and cortex. Although Snx27+/− mice have grossly normal neuroanatomy, we found defects in synaptic function, learning and memory and a reduction in the amounts of ionotropic glutamate receptors (NMDA and AMPA receptors) in these mice. SNX27 interacts with these receptors through its PDZ domain, regulating their recycling to the plasma membrane. We demonstrate a concomitant reduced expression of SNX27 and CCAAT/enhancer binding protein β (C/EBPβ) in Down's syndrome brains and identify C/EBPβ as a transcription factor for SNX27. Down's syndrome causes overexpression of miR-155, a chromosome 21–encoded microRNA that negatively regulates C/EBPβ, thereby reducing SNX27 expression and resulting in synaptic dysfunction. Upregulating SNX27 in the hippocampus of Down's syndrome mice rescues synaptic and cognitive deficits. Our identification of the role of SNX27 in synaptic function establishes a new molecular mechanism of Down's syndrome pathogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cullen, P.J. Endosomal sorting and signalling: an emerging role for sorting nexins. Nat. Rev. Mol. Cell Biol. 9, 574–582 (2008).
Kajii, Y. et al. A developmentally regulated and psychostimulant-inducible novel rat gene mrt1 encoding PDZ-PX proteins isolated in the neocortex. Mol. Psychiatry 8, 434–444 (2003).
Lauffer, B.E. et al. SNX27 mediates PDZ-directed sorting from endosomes to the plasma membrane. J. Cell Biol. 190, 565–574 (2010).
Temkin, P. et al. SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors. Nat. Cell Biol. 13, 715–721 (2011).
Lunn, M.L. et al. A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction. Nat. Neurosci. 10, 1249–1259 (2007).
Joubert, L. et al. New sorting nexin (SNX27) and NHERF specifically interact with the 5–HT4a receptor splice variant: roles in receptor targeting. J. Cell Sci. 117, 5367–5379 (2004).
Cai, L., Loo, L.S., Atlashkin, V., Hanson, B.J. & Hong, W. Deficiency of sorting nexin 27 (SNX27) leads to growth retardation and elevated levels of N-methyl-D-aspartate receptor 2C (NR2C). Mol. Cell Biol. 31, 1734–1747 (2011).
Shepherd, J.D. & Huganir, R.L. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu. Rev. Cell Dev. Biol. 23, 613–643 (2007).
Malinow, R. New developments on the role of NMDA receptors in Alzheimer's disease. Curr. Opin. Neurobiol. 22, 559–563 (2012).
Becker, L.E., Armstrong, D.L. & Chan, F. Dendritic atrophy in children with Down's syndrome. Ann. Neurol. 20, 520–526 (1986).
Weitzdoerfer, R., Dierssen, M., Fountoulakis, M. & Lubec, G. Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure. J. Neural Transm. Suppl. 61, 59–70 (2001).
Petit, T.L., LeBoutillier, J.C., Alfano, D.P. & Becker, L.E. Synaptic development in the human fetus: a morphometric analysis of normal and Down's syndrome neocortex. Exp. Neurol. 83, 13–23 (1984).
Schmidt-Sidor, B., Wisniewski, K.E., Shepard, T.H. & Sersen, E.A. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin. Neuropathol. 9, 181–190 (1990).
Reynolds, G.P. & Warner, C.E. Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue. Neurosci. Lett. 94, 224–227 (1988).
Risser, D., Lubec, G., Cairns, N. & Herrera-Marschitz, M. Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome. Life Sci. 60, 1231–1237 (1997).
Siarey, R.J., Stoll, J., Rapoport, S.I. & Galdzicki, Z. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology 36, 1549–1554 (1997).
Galdzicki, Z., Siarey, R., Pearce, R., Stoll, J. & Rapoport, S.I. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models. Brain Res. Brain Res. Rev. 35, 115–145 (2001).
Barnes, C.A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 93, 74–104 (1979).
Bach, M.E., Hawkins, R.D., Osman, M., Kandel, E.R. & Mayford, M. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81, 905–915 (1995).
Elton, T.S., Sansom, S.E. & Martin, M.M. Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins. RNA Biol. 7, 540–547 (2010).
Keck-Wherley, J. et al. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes. Dev. Neurosci. 33, 451–467 (2011).
He, M., Xu, Z., Ding, T., Kuang, D.M. & Zheng, L. MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPβ. Cell Mol. Immunol. 6, 343–352 (2009).
Rampon, C. et al. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat. Neurosci. 3, 238–244 (2000).
Fernandez, F. et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10, 411–413 (2007).
Davisson, M.T. et al. Segmental trisomy as a mouse model for Down syndrome. Prog. Clin. Biol. Res. 384, 117–133 (1993).
O'Doherty, A. et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309, 2033–2037 (2005).
Ghai, R. et al. Phox homology band 4.1/ezrin/radixin/moesin-like proteins function as molecular scaffolds that interact with cargo receptors and Ras GTPases. Proc. Natl. Acad. Sci. USA 108, 7763–7768 (2011).
Wen, L. et al. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J. Cell Biol. 195, 765–779 (2011).
Muhammad, A. et al. Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Aβ accumulation. Proc. Natl. Acad. Sci. USA 105, 7327–7332 (2008).
Small, S.A. Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease. Arch. Neurol. 65, 323–328 (2008).
Small, S.A. et al. Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann. Neurol. 58, 909–919 (2005).
Vilariño-Güell, C. et al. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet. 89, 162–167 (2011).
Zimprich, A. et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89, 168–175 (2011).
Merhav, M. et al. Behavioral interference and C/EBPβ expression in the insular-cortex reveal a prolonged time period for taste memory consolidation. Learn. Mem. 13, 571–574 (2006).
Milekic, M.H., Pollonini, G. & Alberini, C.M. Temporal requirement of C/EBPβ in the amygdala following reactivation but not acquisition of inhibitory avoidance. Learn. Mem. 14, 504–511 (2007).
Taubenfeld, S.M., Milekic, M.H., Monti, B. & Alberini, C.M. The consolidation of new but not reactivated memory requires hippocampal C/EBPβ. Nat. Neurosci. 4, 813–818 (2001).
Alberini, C.M., Ghirardi, M., Metz, R. & Kandel, E.R. C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76, 1099–1114 (1994).
Cramer, N.P., Best, T.K., Stoffel, M., Siarey, R.J. & Galdzicki, Z. GABAB-GIRK2–mediated signaling in Down syndrome. Adv. Pharmacol. 58, 397–426 (2010).
Best, T.K., Siarey, R.J. & Galdzicki, Z. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current. J. Neurophysiol. 97, 892–900 (2007).
Balana, B. et al. Mechanism underlying selective regulation of G protein-gated inwardly rectifying potassium channels by the psychostimulant-sensitive sorting nexin 27. Proc Natl. Acad. Sci. USA 108, 5831–5836 (2011).
Gomis, R.R., Alarcon, C., Nadal, C., Van Poznak, C. & Massague, J. C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10, 203–214 (2006).
Sterneck, E., Tessarollo, L. & Johnson, P.F. An essential role for C/EBPβ in female reproduction. Genes Dev. 11, 2153–2162 (1997).
Qiu, Z. & Ghosh, A. A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. Neuron 60, 775–787 (2008).
Liu, Y. et al. Intracellular trafficking of presenilin 1 is regulated by β-amyloid precursor protein and phospholipase D1. J. Biol. Chem. 284, 12145–12152 (2009).
Ehlers, M.D. Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28, 511–525 (2000).
Acknowledgements
We thank P. Slesinger (Mount Sinai School of Medicine) for providing the rabbit SNX27-specific antibody and helpful discussion, A. Roberts and the Scripps behavioral core for mouse behavioral analysis, T. Golde and C. Ceballos (University of Florida) for generating AAV, E. Masliah (University of California, San Diego) for providing human brain specimens, P. Greengard (The Rockfeller University) for providing GluR1 and GluR2 constructs, K. Wright (University of California, San Diego) for helping in the transfer of Ts65Dn mice, S. Huang (Sanford-Burnham Medical Research Institute) for helping with statistical analysis, K. Saylor (US National Institutes of Health) for C/EBPβ knockout mouse breeding and tissue collection and A. Brzozowska-Prechtl and L. Lacarra for technical help. This work was supported in part by US National Institutes of Health grants (R01 AG038710, R01 AG021173, R01 NS046673, R01 AG030197 and R01 AG044420 to H.X.; and P01 HD29587, P01 ES016738, P30 NS076411 to S.A.L.) and grants from the Alzheimer's Association (to H.X. and Y. Zhang), the American Health Assistance Foundation (to H.X.), National Natural Science Foundation of China (30973150 and 81161120496 to Y. Zhang), the 973 Prophase Project (2010CB535004 to Y. Zhang) and Natural Science Funds for Distinguished Young Scholar of Fujian Province (2009J06022 to Y. Zhang). Y. Zhang is supported by the Program for New Century Excellent Talents in Universities (NCET), the Fundamental Research Funds for the Central Universities and Fok Ying Tung Education Foundation. This research was supported in part by the Intramural Research Program of the US National Institutes of Health, US National Cancer Institute and Center for Cancer Research.
Author information
Authors and Affiliations
Contributions
X.W. and H.X. conceptualized the study. X.W. designed and performed morphological analysis and biochemical assays, and Y. Zhao performed receptor endocytosis and recycling experiments. X.Z. performed mEPSC and LTP recordings in the SNX27 rescue experiments, and S.A.L. designed and helped analyze these experiments while supervising X.Z. H.B. and Y.M. performed extracellular electrophysiological recordings, and B.R. and F.H.G. supervised H.B. and Y.M., respectively. Y. Zhou analyzed miRNA expression in humans with Down's syndrome and the mouse model. L.S.L. performed endogenous coimmunoprecipitation assays. W.H. provided Snx27 knockout mice and SNX27-specific antibody and supervised L.S.L. and L.C. C.W. and W.C.M. provided Ts65Dn mice and discussion. R.C.T. performed mouse genotyping, Y.C. helped with collecting Alzheimer's disease samples, B.Y. and D.Z. performed whole-cell recordings, and P.F.J. provided C/EBPβ knockout mouse brain samples. Y. Zhang, G.B. and S.A.L. discussed and edited the manuscript. X.W. and H.X. wrote the manuscript. H.X. supervised the project.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–13, Supplementary Tables 1–3 and Supplementary Methods (PDF 1402 kb)
Rights and permissions
About this article
Cite this article
Wang, X., Zhao, Y., Zhang, X. et al. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. Nat Med 19, 473–480 (2013). https://doi.org/10.1038/nm.3117
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3117
This article is cited by
-
Partial loss of Sorting Nexin 27 resembles age- and Down syndrome-associated T cell dysfunctions
Immunity & Ageing (2024)
-
SNX17 Mediates Dendritic Spine Maturation via p140Cap
Molecular Neurobiology (2024)
-
Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach
Journal of Neurology (2024)
-
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
Alzheimer's Research & Therapy (2023)
-
Roles of the miR-155 in Neuroinflammation and Neurological Disorders: A Potent Biological and Therapeutic Target
Cellular and Molecular Neurobiology (2023)